植物孕生物合成途径的解及其在酵母细胞工厂中的应用
Rongsheng Li1, Shuang Guo2, Dong Wang2
1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Metabolic engineering
|March 29, 2025
概括
科学家们设计了一家酵母工厂,利用植物酶从糖中生产孕激素,克服了先前在类固醇生物合成方面的局限性,以实现可持续的药物生产.
科学领域:
- 生物技术和合成生物学
- 代谢工程是代谢工程.
- 植物生物化学 植物生物化学
背景情况:
- 类固醇衍生物在药物治疗中至关重要,但微生物生物合成面临着挑战.
- 现有的方法与低酶活性和关键酶的线粒体局部化作斗争,如细胞染色体P450固醇侧链裂解 (P450scc).
- 克服这些瓶需要有效的P450scc系统和用于类固醇生产的新策略.
研究的目的:
- 为了阐明药用植物Marsdenia tenacissima中的完整的孕激素生物合成途径.
- 识别和描述涉及植物性类固醇合成的关键酶.
- 为高效的孕激素生产设计一种微生物系统.
主要方法:
- 在Marsdenia tenacissima中阐明了孕激素生物合成途径,确定了四种关键酶:MtCYP108,MtCYP150,MtHSD5和MtHSD6.
- 在酵母和植物系统中对酶局部化 (P450scc的内 плазма网膜,HSD的细胞质) 和电子转移链 (植物类型的细胞染色体P450减少酶) 的表征.
- 设计一个酵母细胞工厂,利用这些植物衍生的酶从简单的碳来源合成孕激素.
主要成果:
- 在孕激素路径中确定了两个P450scc酶 (MtCYP108,MtCYP150) 和两个HSD (MtHSD5,MtHSD6).
- 已证实植物衍生P450scc酶局部化到内 плазма网膜中,并利用植物类型的细胞染色体P450减少酶,与动物同类不同.
- 在一个工程酵母细胞工厂中达到1.06g/L的高产量.
结论:
- 在Marsdenia tenacissima中发现了一种新的,高效的孕激素生物合成途径,具有明显的酶局部化.
- 建立了一个功能性的酵母细胞工厂,用于使用植物衍生酶合成孕激素.
- 通过植物性或微生物系统为可持续大规模生产类固醇激素药物铺平了道路.
相关概念视频
Biosynthesis in Bacteria
1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94


